Compare Agilent Technologies Inc (A) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Agilent Technologies Inc trades at $128.23 (market cap $37.04B), while Virgin Galactic Holdings, Inc. trades at $2.63 (market cap $330.34M). The key difference: Agilent Technologies Inc is far larger — about 112.1× Virgin Galactic Holdings, Inc.'s market cap, and Agilent Technologies Inc pays a 0.78% dividend while Virgin Galactic Holdings, Inc. pays none. Which is the better fit depends on your goals.
| A | SPCE | |
|---|---|---|
Market Cap | $37.04B | $330.34M |
Sector | Health | Industrials |
52-Week High | $157.20 | $7.52 |
52-Week Low | $110.24 | $2.17 |
Enterprise Value | $38.59B | $430.19M |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Virgin Galactic (SPCE) trades at $2.57, down 4.81% today, reflecting persistent bearish technical signals and weak fundamentals. The company continues to report significant losses, with a net income margin of -19,781.3% in 2025 and negative cash flow from operations. Recent news highlights volatility tied to SpaceX IPO developments, with SPCE shares experiencing sharp swings. Analyst consensus is mixed, with 29% buy, 41% hold, and 29% sell ratings, indicating cautious sentiment amid ongoing financial challenges.
The outlook remains highly speculative, with investment opportunity hinging on future commercial spaceflight success, but risks are substantial. High cash burn, lack of profitability, and intense competition threaten shareholder value. Without near-term revenue growth or path to profitability, the stock faces significant downside risk despite trading near historical lows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
